These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 22275396)
1. Adult primary and secondary immune thrombocytopenic purpura: a comparative analysis of characteristics and clinical course. Ayesh MH; Alawneh K; Khassawneh B; Khader Y; Kasasbeh A Clin Appl Thromb Hemost; 2013 Jun; 19(3):327-30. PubMed ID: 22275396 [TBL] [Abstract][Full Text] [Related]
2. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [TBL] [Abstract][Full Text] [Related]
3. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China. Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151 [TBL] [Abstract][Full Text] [Related]
4. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura. Abbasi SY; Milhem M; Zaru L Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
6. [Clinical course, diagnostic and therapeutic management of immune thrombocytopenic purpura in children]. Mitura-Lesiak M; Filiks-Litwin B; Malek U; Kowalczyk JR Med Wieku Rozwoj; 2004; 8(4 Pt 1):1004-11. PubMed ID: 15951618 [TBL] [Abstract][Full Text] [Related]
7. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808 [TBL] [Abstract][Full Text] [Related]
8. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Rostami N; Keshtkar-Jahromi M; Rahnavardi M; Keshtkar-Jahromi M; Esfahani FS Am J Hematol; 2008 May; 83(5):376-81. PubMed ID: 18183613 [TBL] [Abstract][Full Text] [Related]
9. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol. Schiavotto C; Castaman G; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755 [TBL] [Abstract][Full Text] [Related]
10. [Forty four pregnancies with idiopathic thrombocytopenic purpura]. Mortensen TB; Jønsson V; Wiik A; Bock JE Ugeskr Laeger; 2002 Aug; 164(34):3968-72. PubMed ID: 12212479 [TBL] [Abstract][Full Text] [Related]
11. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura]. Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309 [TBL] [Abstract][Full Text] [Related]
14. Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura. Blatt J; Weston B; Gold S Pediatr Hematol Oncol; 2010 Feb; 27(1):65-7. PubMed ID: 20121557 [TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Gereige RS; Barrios NJ P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200 [TBL] [Abstract][Full Text] [Related]
16. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568 [TBL] [Abstract][Full Text] [Related]
17. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients. Tsuda H; Tsuji T; Tsuji M; Yamasaki H Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759 [TBL] [Abstract][Full Text] [Related]
18. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Page LK; Psaila B; Provan D; Michael Hamilton J; Jenkins JM; Elish AS; Lesser ML; Bussel JB Br J Haematol; 2007 Jul; 138(2):245-8. PubMed ID: 17542983 [TBL] [Abstract][Full Text] [Related]
19. Chronic immune thrombocytopenic purpura in children: a survey of the canadian experience. Belletrutti M; Ali K; Barnard D; Blanchette V; Chan A; David M; Luke B; Price V; Ritchie B; Wu J; ; J Pediatr Hematol Oncol; 2007 Feb; 29(2):95-100. PubMed ID: 17279005 [TBL] [Abstract][Full Text] [Related]
20. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000]. Kjaersgaard M; Edslev PW; Rosthøj S Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]